NCT05243823
- Conditions
- Postmenopausal Vaginal Atrophy
- Locations
-
- Novo Nordisk Investigational Site Soeborg, Denmark
Clinical trial condition
Postmenopausal Vaginal Atrophy
Explore clinical trials studying Postmenopausal Vaginal Atrophy. Study availability and eligibility vary by location and protocol.
8 public trials
0 recruiting studies
Postmenopausal Vaginal Atrophy trial results
Completed
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
NCT00431132
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
- Novo Nordisk Investigational Site Brno, Czechia
- Novo Nordisk Investigational Site Brno, Czechia
- Novo Nordisk Investigational Site Olomouc, Czechia
- Novo Nordisk Investigational Site Prague, Czechia
NCT00464971
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
Not specified
NCT00465192
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
Not specified
NCT01486979
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
- Novo Nordisk Investigational Site Neu-Ulm, Germany
NCT01507454
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
- Novo Nordisk Investigational Site Mainz, Germany
NCT00108849
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
- Novo Nordisk Investigational Site Mobile, Alabama, United States
- Novo Nordisk Investigational Site Montgomery, Alabama, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Tucson, Arizona, United States
NCT01085877
- Conditions
- Menopause, Postmenopausal Vaginal Atrophy
- Locations
-
- Mainz, Germany